102.17
price down icon0.84%   -0.87
pre-market  Pre-market:  100.55   -1.62   -1.59%
loading
Cardinal Health, Inc. stock is currently priced at $102.17, with a 24-hour trading volume of 2.66M. It has seen a -0.84% decreased in the last 24 hours and a -8.83% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $102.9 pivot point. If it approaches the $102.0 support level, significant changes may occur.
Previous Close:
$103.04
Open:
$102.25
24h Volume:
2.66M
Market Cap:
$24.85B
Revenue:
$216.15B
Net Income/Loss:
$639.00M
P/E Ratio:
167.49
EPS:
0.61
Net Cash Flow:
$3.42B
1W Performance:
-1.32%
1M Performance:
-8.83%
6M Performance:
+9.18%
1Y Performance:
+24.22%
1D Range:
Value
$100.56
$103.10
52W Range:
Value
$77.56
$116.04

Cardinal Health, Inc. Stock (CAH) Company Profile

Name
Name
Cardinal Health, Inc.
Name
Phone
614-757-5000
Name
Address
7000 Cardinal Place, Dublin, OH
Name
Employee
50,000
Name
Twitter
@cardinalhealth
Name
Next Earnings Date
2024-05-02
Name
Latest SEC Filings
Name
CAH's Discussions on Twitter

Cardinal Health, Inc. Stock (CAH) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-09-24 Upgrade Argus Hold → Buy
Jan-03-24 Initiated Barclays Overweight
Dec-14-23 Initiated Wells Fargo Underweight
Jul-10-23 Downgrade Evercore ISI Outperform → In-line
Mar-31-23 Initiated Citigroup Neutral
Feb-03-23 Upgrade Robert W. Baird Neutral → Outperform
Nov-04-22 Upgrade BofA Securities Underperform → Neutral
Aug-22-22 Resumed Morgan Stanley Overweight
May-26-22 Downgrade Barclays Overweight → Equal Weight
May-18-22 Upgrade Evercore ISI In-line → Outperform
Apr-12-22 Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-01-22 Resumed Credit Suisse Neutral
Aug-06-21 Downgrade Deutsche Bank Buy → Hold
Aug-05-21 Downgrade BofA Securities Buy → Underperform
May-10-21 Downgrade Robert W. Baird Outperform → Neutral
Jan-08-21 Upgrade Wolfe Research Underperform → Peer Perform
Nov-02-20 Upgrade Barclays Equal Weight → Overweight
Sep-25-20 Upgrade Deutsche Bank Hold → Buy
Jul-20-20 Upgrade Guggenheim Neutral → Buy
May-15-20 Upgrade UBS Neutral → Buy
Apr-23-20 Resumed Credit Suisse Neutral
Mar-20-20 Upgrade BofA/Merrill Underperform → Buy
Feb-12-20 Upgrade Morgan Stanley Underweight → Equal-Weight
Feb-07-20 Upgrade Robert W. Baird Neutral → Outperform
Dec-16-19 Downgrade Guggenheim Buy → Neutral
Sep-12-19 Initiated Deutsche Bank Hold
Aug-27-19 Downgrade Argus Buy → Hold
Aug-20-19 Upgrade Guggenheim Neutral → Buy
Apr-18-19 Initiated Guggenheim Neutral
Jan-17-19 Initiated UBS Neutral
Nov-16-18 Downgrade Leerink Partners Outperform → Mkt Perform
Apr-24-18 Upgrade Leerink Partners Mkt Perform → Outperform
Apr-02-18 Upgrade Argus Hold → Buy
Mar-08-18 Initiated Barclays Equal Weight
Feb-27-18 Resumed BofA/Merrill Underperform
Jan-05-18 Initiated Evercore ISI In-line
View All

Cardinal Health, Inc. Stock (CAH) Financials Data

Cardinal Health, Inc. (CAH) Revenue 2024

CAH reported a revenue (TTM) of $216.15 billion for the quarter ending December 31, 2023, a +11.99% rise year-over-year.
loading

Cardinal Health, Inc. (CAH) Net Income 2024

CAH net income (TTM) was $639.00 million for the quarter ending December 31, 2023, a +150.20% increase year-over-year.
loading

Cardinal Health, Inc. (CAH) Cash Flow 2024

CAH recorded a free cash flow (TTM) of $3.42 billion for the quarter ending December 31, 2023, a +22.53% increase year-over-year.
loading

Cardinal Health, Inc. (CAH) Earnings per Share 2024

CAH earnings per share (TTM) was $2.54 for the quarter ending December 31, 2023, a +154.62% growth year-over-year.
loading

Cardinal Health, Inc. Stock (CAH) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
Nov 27 '23
Option Exercise
74.10
27,642
2,048,356
71,844
WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
Nov 27 '23
Sale
106.31
36,642
3,895,411
35,202
WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
Aug 28 '23
Option Exercise
71.43
6,712
479,438
50,914
WEITZMAN DEBORAH
CEO, Pharmaceutical Segment
Aug 28 '23
Sale
89.81
6,712
602,805
44,202
Scherer Mary C.
Chief Accounting Officer
Aug 18 '23
Option Exercise
75.36
11,460
863,646
31,344
Scherer Mary C.
Chief Accounting Officer
Aug 18 '23
Sale
86.27
20,695
1,785,358
10,649
Snow Ola M
Chief Human Resources Officer
Aug 17 '23
Option Exercise
71.43
3,907
279,077
52,086
Mason Stephen M
CEO, Medical Segment
Aug 17 '23
Sale
87.32
37,500
3,274,642
37,355
Snow Ola M
Chief Human Resources Officer
Aug 17 '23
Sale
87.41
26,324
2,301,053
25,762
Mayer Jessica L
Chief Legal/Compliance Officer
Aug 17 '23
Sale
87.68
10,668
935,370
84,865
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States and internationally. It provides medical products and pharmaceuticals, and solutions that enhance supply chain efficiency for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company operates through two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. It also provides services to support the development, marketing, and distribution of specialty pharmaceutical products, as well as pharmacy management, and medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; and repackages generic pharmaceuticals and over-the-counter healthcare products. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products. It also distributes a range of national brand products; and medical products to patients' homes, as well as provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
$68.78
price down icon 0.72%
medical_distribution COR
$229.20
price down icon 4.12%
$25.45
price down icon 0.08%
medical_distribution OMI
$24.01
price down icon 2.95%
$11.77
price up icon 7.29%
Cap:     |  Volume (24h):